milestones
Founded 2018
Partnered 2021
Team
Geoffrey von Maltzahn
Jacob Rubens
Mike Severino
Board
LEAD INVESTOR
category
Multi + Other
Immunology
Pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source
No items found.
